President, International Business Unit, Takeda Pharmaceutical
Verified interview transcripts, podcast appearances, and direct quotes from Giles Platford, President, International Business Unit at Takeda Pharmaceutical. AI-verified speaker identity with full-text searchable transcripts.
“40% of the plasma we need to treat patients in Europe today comes from the US and this is an unacceptable situation.”
“I think in the US you got great examples of the special recognition that was given to plasma drive therapies in the inflation reduction act also in the establishment of the plasma caucus which I think is a first of its kind and brings together relevant stakeholders to have dialogue and discussion around the importance...”
“The difference between the average life expectancy in the poorest countries versus the richest countries is about 34 years... that's obviously clearly unacceptable and many of those if I can say premature death could be avoided if there was more equitable access to health care and to medicines and that's why I joined t...”
“90% of the world's plasma comes from five countries the majority of which comes from 70% comes from the US... and it's no coincidence that those five countries represent 90% of all plasma collection... the private sector is active through plasma freezes in collecting plasma and there are appropriate frameworks in place...”
“40% of the plasma that's needed to support those patients is actually sourced from the U.S. so there is a deficit in Europe today and that's why it's important that this legislation is being reviewed right because of course it's it's not as if we have a a huge supply of plasma in the U.S. either so there's that you kno...”
“the legislative text draft currently states that plasma donation infers significant risk now there's no data out there that we are aware of that would give give any proof to that in fact there's a wealth of data out there that shows even at you know pretty high levels of frequency of donation and remember in the U.S pl...”
Giles Platford, President, Plasma-Derived Therapies, Takeda discuses the 'secret sauce' to innovation in Takeda. For more ...
In this episode, Giles Platford, President of Takeda Global Plasma Derived Therapies, discusses Takeda's approach to health ...
Watch a new video featuring PPTA President and CEO Anita Brikman, and Global Executive Board Chair, Giles Platford. In this ...
Reuters Events Pharma's YouTube channel now broadcasts the best presentations, chats and interviews from our conferences.
Reuters Events Pharma’s YouTube channel now broadcasts the best presentations, chats and interviews from our conferences. Reuters Events Pharma’s mission is to make the pharmaceutical industry more open and valued. Our conferences are where leading minds gather to discuss and share strategies that drive value for patients and shine a light on pharma excellence. Look for talks on patient-centricity, digital marketing, RWE, cell & gene therapy, access, diversity, clinical innovation and medical affairs. For more content like this, including panel discussions, articles, in-depth reports & upcom…
In this issue, pharmaphorum editor-in-chief Jonah Comstock sat down (virtually) with Takeda Pharmaceuticals', Giles Platford, ...
An interview with Giles Platford, President Europe & Canada, Takeda Pharmaceutical Company Limited at the eyeforpharma ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Giles Platford.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →